Class A
Renitidine Hydrochloride Capsules Instructions
Please read the instructions carefully and use as directed or purchase and use under the guidance of your pharmacist.
[Medication Name】
Generic Name: Ranitidine Hydrochloride Capsules
English Name:Ranitidine Hydrochloride Capsules
Hanyu Pinyin:Yansuan Leinitiding Jiaonang
[ Ingredients [ =”color:#292929″>】
This product contains the main ingredient ranitidine0.15g. The excipients are sodium carboxymethyl starch, corn starch, silicon dioxide, and magnesium stearate.
[Properties [ =”color:#292929″>】 The contents of this product are off-white to yellow powder or granules.
[Action Category]
This product is an over-the-counter antacid drug. [ Indications】
For the relief of stomach pain, heartburn (heartburn), and acid reflux due to excess stomach acid. [ Specification】0.15g (as ranitidine)[Dosage】
Orally.
Adult once1capsule a day2times a day. Take in the early morning and before bedtime.
[Adverse Reactions】
The following events have been reported in clinical trials or routine treatment with ranitidine, many of which have not been clearly correlated with ranitidine. Headache (sometimes severe) may be associated with ranitidine.
Central nervous system: rare discomfort, dizziness, drowsiness, insomnia, and vertigo. Rare reversible confusion, agitation, depression, and hallucinations, primarily in severely ill elderly patients. Rarely reversible blurred vision suggesting changes in regulatory function. Rarely reversible involuntary movement disorders.
Cardiovascular: as in otherH2receptor antagonist, rare tachycardia, bradycardia, AV block, premature ventricular contractions.
Gastrointestinal: constipation, diarrhea, nausea/vomiting , abdominal discomfort/abdominal pain, rare pancreatitis.
Liver: Hepatocellular, cholestatic, or mixed forms of hepatitis with or without jaundice have occasionally been reported. In such cases, ranitidine should be discontinued immediately. These events are generally reversible, but death has rarely occurred. Hepatic failure is rare.
Musculoskeletal: Rarely arthralgia and myalgia.
Hematology: a few patients present with altered blood counts (leukopenia, granulocytopenia, and thrombocytopenia), which are generally reversible. Rarely, granulocyte deficiency, pancytopenia, sometimes with myelodysplasia and aplastic anemia, and very rarely, acquired immune hemolytic anemia.
Endocrine system: controlled trials in animals and humans have not shown that ranitidine stimulates pituitary hormones or has anti-androgenic activity, and the gynecomastia and impotence caused by cimetidine in hypersecretory patients subsided when ranitidine was used to replace cimetidine. However, impotence and hypogonadism have occasionally been reported in male patients taking ranitidine, and their incidence is similar to that of the normal population. Breast discharge and gynecomastia have been reported rarely in both men and women.
Skin : rash, including rare erythema multiforme. Rare alopecia and vasculitis.
Respiratory: a large epidemiologic study showed that with discontinuation of H2receptor antagonist therapy, patients who were using H2receptor Patients with antagonists are at increased risk of pneumonia. However, the causal relationship between H2receptor antagonists and pneumonia is not clear.
Other: rare hypersensitivity reactions (e.g., bronchospasm, fever, rash, eosinophilia), allergic reactions, angioneurotic edema, acute interstitial nephritis, and mildly elevated serum creatinine.
[Contraindications] 1. 1. Contraindicated in children under 8 years of age. 2. Contraindicated in pregnant and lactating women.
3. Contraindicated if you are allergic to this product and its ingredients. [Precautions] 1. Do not use this product for more than 7 consecutive days without relief of symptoms, consult your physician or pharmacist. 2. Use with caution in elderly patients and patients with hepatic or renal insufficiency. 3. If overdose or serious adverse reactions occur, seek immediate medical attention. 4. Consult your physician or pharmacist for dosage for children over 8 years of age. 5. This product is contraindicated for those who are allergic to it and should be used with caution for those with allergies. 6. Do not use if there is any change in the properties of this product. 7. Keep this product out of the reach of children. 8. Children must be used under adult supervision. 9. If you are using other drugs, consult your physician or pharmacist before using this product.
10. Avoid use in patients with a history of acute porphyria.
[Drug Interactions] 1.Combined with procainamide, the clearance is reduced. 2.Drug interactions may occur if used concurrently with other drugs; consult a physician or pharmacist for details.
3.Alterations in prothrombin time have been reported in combination with warfarin.
4.Renitidine affects intragastricpH values, which may lead to increased absorption (e.g., triazolam, midazolam, glipizide) or decreased absorption (e.g., ketoconazole, atazanavir, dilaudid, gefitinib) of the drug.
[Pharmacological effects]It is a H2receptor inhibitor with inhibitory effect on gastric acid secretion. It is rapidly absorbed via the gastrointestinal tract after oral administration. [ Storage】 Shaded, sealed, at 25°C below in a dry place.
[Packaging]High density polyethylene bottles for oral solids,30capsules/bottle.
[Expiration Date]18months
[Execution Standard】
[Approval number] 国药准字 H13021317
[Date of revision of instruction]
[Manufacturer】Company Name. Shijiazhuang Ouyi Pharmaceutical Co., LtdProduction Address: Yangzi Road, Shijiazhuang Economic and Technological Development Zone88No.Postal address :equals”>Postal Code:052165Phone Number:8009111886(Please call from a landline) 4006128666 =”font-family:equals”>Fax number:0311-67809458
Contact the manufacturer if you have any questions